期刊文献+

推动心脏再同步治疗在我国的合理应用 被引量:2

Promoting rational use of cardiac resynchronization therapy in China
原文传递
导出
摘要 心脏再同步治疗(CRT)已成为伴有心室传导障碍心力衰竭患者的一线治疗方法。目前我国CRT应用正步入快速发展期,每年有近两千例心力衰竭患者接受CRT,并且这一数字以每年30%以上的速度增长。如何让每一例接受CRT的患者获益是一个现实问题。遗憾的是,目前国内外报道的CRT反应率并不理想,应用不同标准判断的CRT无反应率介于30%-50%。因此,提高CRT反应率,增加CRT效价比对于我国这样一个发展中国家尤为重要。
作者 华伟
出处 《中华心律失常学杂志》 2012年第1期5-5,共1页 Chinese Journal of Cardiac Arrhythmias
  • 相关文献

同被引文献16

  • 1Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation, 2008,117(21 ) : e350-408.
  • 2Vardas PE, Auficchio A, Blanc J J, et al. European practice guidelines on cardiac pacemakers and cardiac resynchronization therapy. Working Group of the European Society of Cardiology (ESC) on cardiac pacemakers and cardiac resynchronization therapy. Developed in collaboration with the European Heart Rhythm Association. Rev Esp Cardiol, 2007,60(12) : 1272.
  • 3Wikstrom G, Blomstrb'm-Lundqvist C, Andren B, et al. The effects of aetiology on outcome in patients treated with cardiac resynchrenization therapy in the CARE-HF trial. Eur Heart J,2009,30(7):782-788.
  • 4Dickstein K, Vardas PE, Aufiechio A, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J, 2010,31 (21):2677- 2687.
  • 5Stevenson WG, Hemandez AF, Carson PE,et al. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. J Card Fail, 2012,18(2):94-106.
  • 6Bleeker GB, Schalij M J, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients withend-stage heart failure. J Cardiovasc Electrophysiol, 2004,15 (5) : 544-549.
  • 7Yu CM, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart, 2003,89( 1 ) : 54-60.
  • 8Bax JJ, Ansalone G, Breithardt OA, et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. J Am Coil Cardiol, 2004,44( 1 ) : 1-9.
  • 9Ansalone G, Giannantoni P, Ricci R, et al. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coil Cardiol, 2002,39 (3) : 489-499.
  • 10Liao YH. Functional analysis of autoantibodies against ADP/ATP carrier from dilated cardiomyopathy. Int J Cardial, 1996,54 (2) : 165-169.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部